Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Aug 15, 2011 · 10-Q · 46 days after period end · 0001144204-11-047222
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $279.18K | $157.70K |
| Net Income | -$598.05K | -$1.35M |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 15, 2011 · 46 d after period end
